StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Sanofi (SNY)

Press Release: Sanofi launches 2026 global employee stock purchase plan June 4, 2026 4:07 AM - Globe NewsWire Sanofi partners with Snowflake to build AI agent for sales teams June 2, 2026 9:09 AM - StreetInsider Form SD Sanofi May 28, 2026 6:07 AM - SEC Filing Form 6-K Sanofi For: May 27 May 27, 2026 10:32 AM - SEC Filing China holds roundtable with over 50 foreign pharmaceutical firms May 22, 2026 9:54 AM - StreetInsider China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck May 22, 2026 9:24 AM - StreetInsider Sanofi reports positive phase 2 trial results for AATD treatment May 18, 2026 3:30 PM - StreetInsider Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD   May 18, 2026 3:30 PM - Globe NewsWire Form 13F-HR Sanofi For: Mar 31 May 7, 2026 8:47 AM - SEC Filing Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1 May 6, 2026 12:42 PM - PR NewsWire Form 6-K Sanofi For: May 05 May 5, 2026 6:08 AM - SEC Filing Sanofi expands AI center in Toronto with $294 million investment May 4, 2026 1:02 PM - StreetInsider Morgan Stanley Downgrades Sanofi (SNY) to Equalweight May 1, 2026 3:39 PM - StreetInsider Sanofi names Belén Garijo as CEO following shareholder approval April 29, 2026 12:00 PM - StreetInsider Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi April 29, 2026 12:00 PM - Globe NewsWire Regeneron beats first quarter estimates on Dupixent strength April 29, 2026 6:55 AM - StreetInsider Form 6-K Sanofi For: Apr 29 April 29, 2026 6:11 AM - SEC Filing Form 6-K Sanofi For: Apr 27 April 27, 2026 12:58 PM - SEC Filing Sanofi drug gets EU panel backing for progressive multiple sclerosis April 24, 2026 6:10 AM - StreetInsider Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses April 24, 2026 6:09 AM - Globe NewsWire Form 6-K Sanofi For: Mar 31 April 23, 2026 7:20 AM - SEC Filing Sanofi climbs as strong Dupixent sales drive Q1 revenue and profit beat April 23, 2026 6:22 AM - StreetInsider Sanofi (SNY) Tops Q1 EPS by 9c April 23, 2026 2:41 AM - StreetInsider Press Release: Q1 2026: double-digit sales and business EPS growth April 23, 2026 1:41 AM - Globe NewsWire FDA approves Sanofi's Tzield for children as young as one year old April 22, 2026 1:09 AM - StreetInsider Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children April 22, 2026 1:05 AM - Globe NewsWire Goldman Sachs sees nearly 140% upside in this biopharma stock April 20, 2026 7:30 AM - StreetInsider BNP Paribas Exane Downgrades Sanofi (SNY) to Neutral April 20, 2026 4:26 AM - StreetInsider Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study April 18, 2026 6:00 AM - Globe NewsWire Form 6-K Sanofi For: Apr 15 April 15, 2026 6:57 AM - SEC Filing Sanofi (SAN:FP) (SNY) PT Raised to EUR82 at Citi April 13, 2026 6:32 AM - StreetInsider Form SCHEDULE 13G/A Sanofi Filed by: Amundi April 10, 2026 9:58 AM - SEC Filing Sanofi's lunsekimig meets goals in asthma, nasal polyps studies April 7, 2026 1:01 AM - StreetInsider Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP April 7, 2026 1:01 AM - Globe NewsWire Form 6-K Sanofi For: Mar 31 March 31, 2026 12:19 PM - SEC Filing Sanofi (SNY) PT Lowered to $55 at Morgan Stanley March 31, 2026 5:59 AM - StreetInsider Sanofi's amlitelimab shows positive results in atopic dermatitis trials March 28, 2026 11:00 AM - StreetInsider Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session March 28, 2026 11:00 AM - Globe NewsWire Form 6-K Sanofi For: Mar 24 March 24, 2026 11:57 AM - SEC Filing US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters March 16, 2026 3:46 PM - StreetInsider Form 6-K Sanofi For: Mar 10 March 10, 2026 10:41 AM - SEC Filing Full Article List